R
Robeauté
We are developing a sub millimetric microrobot that moves in the brain in curved lines (3D) with sub millimetric precision allowing to access complex areas of the brain in multiple locations to gather…
About Robeauté
Robeauté, founded in 2017 by Joana Cartocci and Bertrand Duplat, is a Paris-based company developing a new class of therapeutic microrobots for neurosurgery.
Read full description
Duplat's background in robotics, including his work at McGill University, combined with Cartocci's leadership, has positioned the company at the forefront of medical technology. The team is described as multidisciplinary and multicultural, reflecting a global approach to solving complex medical challenges.
The company's core product is a microrobotic platform designed to enhance surgical procedures. These microrobots are engineered for the diagnosis, treatment, and monitoring of the brain, offering a level of flexibility and precision that is not possible with current technologies. The technology is intended to be minimally invasive, allowing access to difficult-to-reach areas of the brain for various therapeutic and diagnostic applications.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Paris, France
- Employees
- 44
- Open positions
- 11
- Dealroom signal
- 88.2/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Neurology, Core AI, Spinout, EIC, Medical Robots, Headstart (EIT Health)
- Technology
- Artificial Intelligence, Deep Tech, Nanotech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jan 2025 | $30M | $119M | Brainlab · Cherry Ventures · Kindred Ventures · Plural | ↗ |
| GRANT✓Other financing | Oct 2024 | $2.5M | — | European Innovation Council | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Robeauté is 2.3K monthly website visits, up 15% over the last three months. Robeauté's team grew 12.8% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
APEX Ventures
Urania Ventures
European Innovation Council
Series A6 investors entered at this stage
Cherry Ventures
Kindred Ventures
Plural
Brainlab
LocalGlobe
Think.Health
Other known investors6 additional known investors
EIT Health
MedTech Innovator
SATT LUTECH
Sorbonne University- MWMaru Winnacker
Roxanne Varza
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Robeauté on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Robeauté’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.